| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 20.264 | 63.716 | 98.670 |
| Total Income - EUR | - | - | - | - | - | - | - | 20.264 | 63.716 | 98.670 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 1.951 | 12.431 | 17.971 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 18.313 | 51.285 | 80.698 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 17.717 | 50.660 | 77.719 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 0 |
Check the financial reports for the company - Jianumihaela Rxmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | - | 18.838 | 29.240 | 123.363 |
| Inventories | - | - | - | - | - | - | - | 793 | 791 | 1.016 |
| Receivables | - | - | - | - | - | - | - | 17.076 | 17.024 | 103.510 |
| Cash | - | - | - | - | - | - | - | 968 | 11.424 | 18.836 |
| Shareholders Funds | - | - | - | - | - | - | - | 17.757 | 25.514 | 103.090 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 1.080 | 3.726 | 20.272 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Jianumihaela Rxmed S.r.l.